Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone in Alzheimer's Disease
NCT00000178Phase 3Completed
- Sponsor
- National Institute on Aging
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) comparing Prednisone with Placebo (2 arms). Primary endpoint: Alzheimer's Disease Assessment Scale - Cognitive Subscale at 1 year. Status: completed.
02
Drugs
prednisone
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00000178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000178.